1
|
Saw S, Tan A, Chen J, Lai G, Hlaing N, Takano A, Lau D, Yeong J, Lim K, Skanderup A, Chan J, Teh Y, Rajasekaran T, Jain A, Tan W, Ng Q, Kanesvaran R, Lim WT, Tan E, Ang MK, Tan D. EP16.03-036 Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.1097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
2
|
Lai G, Alvarez J, Yeo J, Sim N, Tan A, Zhou S, Suteja L, Lim T, Rohatgi N, Yeong J, Takano A, Lim K, Gogna A, Too C, Zhuang K, Jain A, Tan W, Kanesvaran R, Ng Q, Ang M, Rajasekaran T, Wang L, Toh C, Lim W, Tam W, Ginhoux F, Tan S, Skanderup A, Tan D, Tan E. OA01.06 Randomised Phase 2 Study of Nivolumab (N) Versus Nivolumab and Ipilimumab (NI) Combination in EGFR Mutant NSCLC. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.274] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
3
|
Tan A, Chua K, Teng Y, Takano A, Alvarez J, Nahar R, Rohatgi N, Lai G, Aung Z, Yeong J, Lim K, Naeini M, Kassam I, Jain A, Tan W, Gogna A, Too C, Kanesvaran R, Ng Q, Ang M, Rajasekaran T, Devanand A, Phua G, Tan B, Lee Y, Wang L, Teo A, Khng A, Lim M, Suteja L, Toh C, Lim W, Iyer N, Tam W, Tan E, Zhai W, Hillmer A, Skanderup A, Tan D. MA13.08 Genomic and Transcriptomic Features of Distinct Resistance Trajectories in EGFR Mutant Non-Small Cell Lung Cancer (NSCLC). J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
4
|
Han S, Yeong J, Lim C, Ang MK, Lim W, Toh C, Ng Q, Tan D, Lim T, Loh J, Tanako A, Kanesvaran R, Tan W, Rajasekaran T, Nei W, Jain A. Somatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy304.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
5
|
Rashid S, Yeong J, Fitzgerald C. Clinical and pathological characteristics of young women diagnosed with breast cancer presenting in a ten year period to a district general hospital in a socioeconomically deprived region. Eur J Cancer 2018. [DOI: 10.1016/s0959-8049(18)30667-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
6
|
Khor L, Sultana R, Yeong J, Huang H, Teo J, Yuen J, Tan P. Prognostic grade grouping in prostate cancer of Singapore men. Pathology 2017. [DOI: 10.1016/j.pathol.2016.09.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Delbaere K, Valenzuela T, Woodbury A, Davies T, Yeong J, Steffens D, Miles L, Pickett L, Zijlstra GAR, Clemson L, Close JCT, Howard K, Lord SR. Evaluating the effectiveness of a home-based exercise programme delivered through a tablet computer for preventing falls in older community-dwelling people over 2 years: study protocol for the Standing Tall randomised controlled trial. BMJ Open 2015; 5:e009173. [PMID: 26493461 PMCID: PMC4620168 DOI: 10.1136/bmjopen-2015-009173] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
INTRODUCTION In order to prevent falls, older people should exercise for at least 2 h per week for 6 months, with a strong focus on balance exercises. This article describes the design of a randomised controlled trial to evaluate the effectiveness of a home-based exercise programme delivered through a tablet computer to prevent falls in older people. METHODS AND ANALYSIS Participants aged 70 years or older, living in the community in Sydney will be recruited and randomly allocated to an intervention or control group. The intervention consists of a tailored, home-based balance training delivered through a tablet computer. Intervention participants will be asked to complete 2 h of exercises per week for 2 years. Both groups will receive an education programme focused on health-related information relevant to older adults, delivered through the tablet computer via weekly fact sheets. Primary outcome measures include number of fallers and falls rate recorded in weekly fall diaries at 12 months. A sample size of 500 will be necessary to see an effect on falls rate. Secondary outcome measures include concern about falling, depressive symptoms, health-related quality of life and physical activity levels (in all 500 participants); and physiological fall risk, balance, functional mobility, gait, stepping and cognitive performance (in a subsample of 200 participants). Adherence, acceptability, usability and enjoyment will be recorded in intervention group participants over 2 years. Data will be analysed using the intention-to-treat principle. Secondary analyses are planned in people with greater adherence. Economic analyses will be assessed from a health and community care provider perspective. ETHICS AND DISSEMINATION Ethical approval was obtained from UNSW Ethics Committee in December 2014 (ref number HC#14/266). Outcomes will be disseminated through publication in peer-reviewed journals and presentations at international conferences. TRIAL REGISTRATION NUMBER Australian New Zealand Clinical Trials Registry (ACTRN)12615000138583.
Collapse
Affiliation(s)
- K Delbaere
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
| | - T Valenzuela
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
| | - A Woodbury
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
| | - T Davies
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
| | - J Yeong
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
| | - D Steffens
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
| | - L Miles
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
| | - L Pickett
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
| | - G A R Zijlstra
- Department of Health Services Research—Focusing on Chronic Care and Ageing, CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands
| | - L Clemson
- Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia
- Ageing Work and Health Research Unit, Faculty of Health Sciences, The University of Sydney, Lidcombe, New South Wales, Australia
| | - J C T Close
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
- Prince of Wales Clinical School, Sydney, New South Wales, Australia
| | - K Howard
- Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia
- Institute for Choice UniSA, North Sydney, New South Wales, Australia
| | - S R Lord
- Neuroscience Research Australia, University of New South Wales, Sydney, New South Wales, Australia
| |
Collapse
|